Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Evonik Industries AGXSWX:EVK 71 Days Sales Outstanding is 42.11 as of Jun. 2026, which is 2% below its 10-year median of 42.77. GuruFocus rates XSWX:EVK with a GF Score™ of 71/100 and a GF Value™ of CHF14.98. The stock has 10 warning signs investors should review. Among 1,582 Chemicals companies, Evonik Industries AG ranks better than 74.84% on this metric.
Evonik Industries AG (XSWX:EVK) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Evonik Industries AG Days Sales Outstanding Related Terms
Evonik Industries AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Evonik Industries AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:EVK vs LIN, SHW, ECL: Days Sales Outstanding Comparison
For the Specialty Chemicals subindustry, Evonik Industries AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evonik Industries AG Days Sales Outstanding vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Evonik Industries AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Evonik Industries AG's Days Sales Outstanding falls into.
Evonik Industries AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evonik Industries AG (XSWX:EVK) has a Days Sales Outstanding of 42.11 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Evonik Industries AG and its competitors. This is near median its historical median of 42.77. Over the past decade, Evonik Industries AG's Days Sales Outstanding has ranged from 38.31 to 49.54. According to the industry distribution chart, Evonik Industries AG ranks #398 out of 1582 companies in the Chemicals industry, placing it in the top 25.2%.
Is Evonik Industries AG's Days Sales Outstanding too high?
Evonik Industries AG's current Days Sales Outstanding of 42.11 is near median its 10-year median of 42.77. Over the past 10 years, this metric has ranged from a low of 38.31 to a high of 49.54. The Chemicals industry median Days Sales Outstanding is 63.49. Evonik Industries AG's value of 42.11 is 33.7% below this industry median. Based on the distribution chart, Evonik Industries AG ranks #398 out of 1582 companies in the Chemicals industry, which is above the industry midpoint. Overall, Evonik Industries AG has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Days Sales Outstanding compare to LIN and SHW?
According to the Chemicals industry distribution chart, Evonik Industries AG ranks #398 out of 1582 companies for Days Sales Outstanding. This puts Evonik Industries AG in the upper half of its industry. The industry median Days Sales Outstanding is 63.49. Evonik Industries AG's value of 42.11 is 33.7% below this benchmark. Historically, Evonik Industries AG's own Days Sales Outstanding has ranged from 38.31 to 49.54 over the past decade. While the company's 10-year median is 42.77 vs. the industry median of 63.49, Evonik Industries AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Chemicals company?
The median Days Sales Outstanding among Chemicals companies is 63.49, based on 1,582 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evonik Industries AG's current Days Sales Outstanding of 42.11 is 33.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Evonik Industries AG and its competitors. For the Chemicals industry, the median Days Sales Outstanding is 63.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evonik Industries AG's current Days Sales Outstanding is 42.11, which is near median its own 10-year median of 42.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Evonik Industries AG (XSWX:EVK) has a current Days Sales Outstanding of 42.11. The stock's GF Value™ is CHF14.98, compared to a current price of CHF16.83 — trading 12.3% above its estimated fair value. The current Days Sales Outstanding is 42.11, which is near median its 10-year median of 42.77 and 33.7% below the Chemicals industry median of 63.49. Evonik Industries AG's overall GF Score™ is 71/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current Days Sales Outstanding is 42.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?
Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued.
The current stock price of CHF16.83 is trading 12.3% above its estimated GF Value™ of CHF14.98.
Key valuation signals for XSWX:EVK:
Days Sales Outstanding: 42.11 (near median its 10-year median of 42.77)
GF Value™: CHF14.98 vs. price of CHF16.83 (12.3% above fair value)
Industry Position: 33.7% below the Chemicals median (#398 of 1582)
No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
71GF Score
Get the complete analysis for XSWX:EVK
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EVK has been successfully added to your 
